These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. New onset diabetes during antihypertensive therapy. Alderman MH Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139 [TBL] [Abstract][Full Text] [Related]
27. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT; Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular risk reduction: impact of an international project]. Colle B; Brusaferro S; Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604 [TBL] [Abstract][Full Text] [Related]
29. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Ezzati M; Oza S; Danaei G; Murray CJ Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146 [TBL] [Abstract][Full Text] [Related]
30. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. Sundborn G; Metcalf PA; Gentles D; Scragg RK; Schaaf D; Dyall L; Black P; Jackson R N Z Med J; 2008 Sep; 121(1281):28-39. PubMed ID: 18797481 [TBL] [Abstract][Full Text] [Related]
31. High blood pressure in Latin America: a call to action. Rubinstein A; Alcocer L; Chagas A Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117 [TBL] [Abstract][Full Text] [Related]
32. The global burden of cardiovascular disease. Deaton C; Froelicher ES; Wu LH; Ho C; Shishani K; Jaarsma T J Cardiovasc Nurs; 2011; 26(4 Suppl):S5-14. PubMed ID: 21659814 [TBL] [Abstract][Full Text] [Related]
34. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus. O'Neill SG; Pego-Reigosa JM; Hingorani AD; Bessant R; Isenberg DA; Rahman A Rheumatology (Oxford); 2009 May; 48(5):573-5. PubMed ID: 19273540 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk factors and dementia. Fillit H; Nash DT; Rundek T; Zuckerman A Am J Geriatr Pharmacother; 2008 Jun; 6(2):100-18. PubMed ID: 18675769 [TBL] [Abstract][Full Text] [Related]
36. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy. Dahlöf B J Hum Hypertens; 2009 Feb; 23(2):77-85. PubMed ID: 18685606 [TBL] [Abstract][Full Text] [Related]
37. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs. Pierson CA; Epstein BJ; Roberts ME J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336 [No Abstract] [Full Text] [Related]
38. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice. Cao Y; DiGiacomo M; Du HY; Ollerton E; Davidson P J Cardiovasc Nurs; 2008; 23(5):386-94; quiz 395-6. PubMed ID: 18728510 [TBL] [Abstract][Full Text] [Related]
39. Is migration to Sweden associated with increased prevalence of risk factors for cardiovascular disease? Koochek A; Mirmiran P; Azizi T; Padyab M; Johansson SE; Karlström B; Azizi F; Sundquist J Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):78-82. PubMed ID: 18277190 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit. Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]